Thrombospondin-1 and -2 messenger RNA expression in epithelial ovarian tumor

J. Kodama, I. Hashimoto, N. Seki, A. Hongo, M. Yoshinouchi, H. Okuda, T. Kudo

Research output: Contribution to journalArticle

27 Citations (Scopus)

Abstract

Background: The role of thrombospondin (TSP) in tumor progression remains controversial. The association of TSP with clinicopathological features regarding prognostic significance was examined in patients with epithelial ovarian tumor. Materials and Methods: Gene expression of TSP-1 and TSP-2 was assessed by reverse transcriptase-polymerase chain reaction in 6 borderline and 29 malignant epithelial ovarian tumors. Results: TSP-1 mRNA expression was detected in 14 out of the 29 malignant epithelial ovarian tumors (48.3%), whereas TSP-2 mRNA expression was detected in 7 malignant epithelial ovarian tumors (24.1%). In contrast, no specimen from the borderline epithelial ovarian tumors expressed TSP mRNA. TSP-1 expression was significantly higher in tumors with advanced stage, massive ascites, positive peritoneal cytology and high grade. TSP-2 expression was significantly higher in tumors with massive ascites. Patients exhibiting TSP-1 and -2 mRNA expression demonstrated a markedly poorer prognosis than those lacking TSP-1 and -2 mRNA expression. Conclusion: These findings provide evidence that TSP expression may be associated with an aggressive phenotype in this class of neoplasm.

Original languageEnglish
Pages (from-to)2983-2987
Number of pages5
JournalAnticancer Research
Volume21
Issue number4 B
Publication statusPublished - 2001

Fingerprint

Thrombospondin 1
Thrombospondins
Messenger RNA
Neoplasms
Carcinoma
Ascites
Reverse Transcriptase Polymerase Chain Reaction
Cell Biology
thrombospondin 2
Phenotype
Gene Expression

Keywords

  • Epithelial ovarian tumor
  • Prognosis
  • Thrombospondin

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Kodama, J., Hashimoto, I., Seki, N., Hongo, A., Yoshinouchi, M., Okuda, H., & Kudo, T. (2001). Thrombospondin-1 and -2 messenger RNA expression in epithelial ovarian tumor. Anticancer Research, 21(4 B), 2983-2987.

Thrombospondin-1 and -2 messenger RNA expression in epithelial ovarian tumor. / Kodama, J.; Hashimoto, I.; Seki, N.; Hongo, A.; Yoshinouchi, M.; Okuda, H.; Kudo, T.

In: Anticancer Research, Vol. 21, No. 4 B, 2001, p. 2983-2987.

Research output: Contribution to journalArticle

Kodama, J, Hashimoto, I, Seki, N, Hongo, A, Yoshinouchi, M, Okuda, H & Kudo, T 2001, 'Thrombospondin-1 and -2 messenger RNA expression in epithelial ovarian tumor', Anticancer Research, vol. 21, no. 4 B, pp. 2983-2987.
Kodama J, Hashimoto I, Seki N, Hongo A, Yoshinouchi M, Okuda H et al. Thrombospondin-1 and -2 messenger RNA expression in epithelial ovarian tumor. Anticancer Research. 2001;21(4 B):2983-2987.
Kodama, J. ; Hashimoto, I. ; Seki, N. ; Hongo, A. ; Yoshinouchi, M. ; Okuda, H. ; Kudo, T. / Thrombospondin-1 and -2 messenger RNA expression in epithelial ovarian tumor. In: Anticancer Research. 2001 ; Vol. 21, No. 4 B. pp. 2983-2987.
@article{a50a9dddccdb45ecbd0468ad36085315,
title = "Thrombospondin-1 and -2 messenger RNA expression in epithelial ovarian tumor",
abstract = "Background: The role of thrombospondin (TSP) in tumor progression remains controversial. The association of TSP with clinicopathological features regarding prognostic significance was examined in patients with epithelial ovarian tumor. Materials and Methods: Gene expression of TSP-1 and TSP-2 was assessed by reverse transcriptase-polymerase chain reaction in 6 borderline and 29 malignant epithelial ovarian tumors. Results: TSP-1 mRNA expression was detected in 14 out of the 29 malignant epithelial ovarian tumors (48.3{\%}), whereas TSP-2 mRNA expression was detected in 7 malignant epithelial ovarian tumors (24.1{\%}). In contrast, no specimen from the borderline epithelial ovarian tumors expressed TSP mRNA. TSP-1 expression was significantly higher in tumors with advanced stage, massive ascites, positive peritoneal cytology and high grade. TSP-2 expression was significantly higher in tumors with massive ascites. Patients exhibiting TSP-1 and -2 mRNA expression demonstrated a markedly poorer prognosis than those lacking TSP-1 and -2 mRNA expression. Conclusion: These findings provide evidence that TSP expression may be associated with an aggressive phenotype in this class of neoplasm.",
keywords = "Epithelial ovarian tumor, Prognosis, Thrombospondin",
author = "J. Kodama and I. Hashimoto and N. Seki and A. Hongo and M. Yoshinouchi and H. Okuda and T. Kudo",
year = "2001",
language = "English",
volume = "21",
pages = "2983--2987",
journal = "Anticancer Research",
issn = "0250-7005",
publisher = "International Institute of Anticancer Research",
number = "4 B",

}

TY - JOUR

T1 - Thrombospondin-1 and -2 messenger RNA expression in epithelial ovarian tumor

AU - Kodama, J.

AU - Hashimoto, I.

AU - Seki, N.

AU - Hongo, A.

AU - Yoshinouchi, M.

AU - Okuda, H.

AU - Kudo, T.

PY - 2001

Y1 - 2001

N2 - Background: The role of thrombospondin (TSP) in tumor progression remains controversial. The association of TSP with clinicopathological features regarding prognostic significance was examined in patients with epithelial ovarian tumor. Materials and Methods: Gene expression of TSP-1 and TSP-2 was assessed by reverse transcriptase-polymerase chain reaction in 6 borderline and 29 malignant epithelial ovarian tumors. Results: TSP-1 mRNA expression was detected in 14 out of the 29 malignant epithelial ovarian tumors (48.3%), whereas TSP-2 mRNA expression was detected in 7 malignant epithelial ovarian tumors (24.1%). In contrast, no specimen from the borderline epithelial ovarian tumors expressed TSP mRNA. TSP-1 expression was significantly higher in tumors with advanced stage, massive ascites, positive peritoneal cytology and high grade. TSP-2 expression was significantly higher in tumors with massive ascites. Patients exhibiting TSP-1 and -2 mRNA expression demonstrated a markedly poorer prognosis than those lacking TSP-1 and -2 mRNA expression. Conclusion: These findings provide evidence that TSP expression may be associated with an aggressive phenotype in this class of neoplasm.

AB - Background: The role of thrombospondin (TSP) in tumor progression remains controversial. The association of TSP with clinicopathological features regarding prognostic significance was examined in patients with epithelial ovarian tumor. Materials and Methods: Gene expression of TSP-1 and TSP-2 was assessed by reverse transcriptase-polymerase chain reaction in 6 borderline and 29 malignant epithelial ovarian tumors. Results: TSP-1 mRNA expression was detected in 14 out of the 29 malignant epithelial ovarian tumors (48.3%), whereas TSP-2 mRNA expression was detected in 7 malignant epithelial ovarian tumors (24.1%). In contrast, no specimen from the borderline epithelial ovarian tumors expressed TSP mRNA. TSP-1 expression was significantly higher in tumors with advanced stage, massive ascites, positive peritoneal cytology and high grade. TSP-2 expression was significantly higher in tumors with massive ascites. Patients exhibiting TSP-1 and -2 mRNA expression demonstrated a markedly poorer prognosis than those lacking TSP-1 and -2 mRNA expression. Conclusion: These findings provide evidence that TSP expression may be associated with an aggressive phenotype in this class of neoplasm.

KW - Epithelial ovarian tumor

KW - Prognosis

KW - Thrombospondin

UR - http://www.scopus.com/inward/record.url?scp=0035165350&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035165350&partnerID=8YFLogxK

M3 - Article

C2 - 11712798

AN - SCOPUS:0035165350

VL - 21

SP - 2983

EP - 2987

JO - Anticancer Research

JF - Anticancer Research

SN - 0250-7005

IS - 4 B

ER -